Advisory Committees

2017 Meeting Materials, Pediatric Advisory Committee

Designated Federal Officer: Marieann Brill, MBA, RAC, MT (ASCP), 240-402-3838

Persons with disabilities having problems accessing the PDF files below may call 240-402-3838 for assistance.

September 11, 2017 Meeting of the Pediatric Advisory Committee

Benefit/Risk Assessment of Prescription Opioid Antitussive Products for Treatment of Cough in Pediatric Patients

Page Last Updated: 09/18/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English